| Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. NK Banda, J Bernier, DK Kurahara, R Kurrle, N Haigwood, RP Sekaly, ... The Journal of experimental medicine 176 (4), 1099-1106, 1992 | 858 | 1992 |
| Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys R Shibata, T Igarashi, N Haigwood, A Buckler–White, R Ogert, W Ross, ... Nature medicine 5 (2), 204-210, 1999 | 711 | 1999 |
| Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin M Zhang, B Gaschen, W Blay, B Foley, N Haigwood, C Kuiken, B Korber Glycobiology 14 (12), 1229-1246, 2004 | 557 | 2004 |
| Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells BS Chapman, RM Thayer, KA Vincent, NL Haigwood Nucleic acids research 19 (14), 3979-3986, 1991 | 487 | 1991 |
| Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120 KS Steimer, CJ Scandella, PV Skiles, NL Haigwood Science 254 (5028), 105-108, 1991 | 307 | 1991 |
| Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines JR Mascola, P D'Souza, P Gilbert, BH Hahn, NL Haigwood, L Morris, ... Journal of virology 79 (16), 10103-10107, 2005 | 300 | 2005 |
| Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries CF Barbas III, TA Collet, W Amberg, P Roben, JM Binley, D Hoekstra, ... Journal of molecular biology 230 (3), 812-823, 1993 | 299 | 1993 |
| Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival A Watson, J Ranchalis, B Travis, J McClure, W Sutton, PR Johnson, ... Journal of virology 71 (1), 284-290, 1997 | 277 | 1997 |
| Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasma T Igarashi, C Brown, A Azadegan, N Haigwood, D Dimitrov, MA Martin, ... Nature medicine 5 (2), 211-216, 1999 | 207 | 1999 |
| DNA sequence organization of the β-globin complex in the BALB/c mouse CL Jahn, CA Hutchison III, SJ Phillips, S Weaver, NL Haigwood, ... Cell 21 (1), 159-168, 1980 | 203 | 1980 |
| Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer … Y Nishimura, T Igarashi, N Haigwood, R Sadjadpour, RJ Plishka, ... Journal of virology 76 (5), 2123-2130, 2002 | 195 | 2002 |
| Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques AJ Hessell, JP Jaworski, E Epson, K Matsuda, S Pandey, C Kahl, J Reed, ... Nature medicine 22 (4), 362-368, 2016 | 180 | 2016 |
| Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile NL Haigwood, A Watson, WF Sutton, J McClure, A Lewis, J Ranchalis, ... Immunology Letters 51 (1-2), 107-114, 1996 | 178 | 1996 |
| DNA vaccine strategies: candidates for immune modulation and immunization regimens NA Doria-Rose, NL Haigwood Methods 31 (3), 207-216, 2003 | 172 | 2003 |
| Human natural killer cells mediate adaptive immunity to viral antigens R Nikzad, LS Angelo, K Aviles-Padilla, DT Le, VK Singh, L Bimler, ... Science immunology 4 (35), eaat8116, 2019 | 167 | 2019 |
| Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons NL Haigwood, PL Nara, E Brooks, GA Van Nest, G Ott, KW Higgins, ... Journal of virology 66 (1), 172-182, 1992 | 163 | 1992 |
| Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques CT Ng, JP Jaworski, P Jayaraman, WF Sutton, P Delio, LR Kuller, ... Nature medicine 16 (10), 1117-1119, 2010 | 161 | 2010 |
| Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development Y Nishimura, T Igarashi, NL Haigwood, R Sadjadpour, OK Donau, ... Proceedings of the National Academy of Sciences 100 (25), 15131-15136, 2003 | 159 | 2003 |
| Use of broadly neutralizing antibodies for HIV‐1 prevention A Pegu, AJ Hessell, JR Mascola, NL Haigwood Immunological reviews 275 (1), 296-312, 2017 | 158 | 2017 |
| Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating … NA Doria-Rose, GH Learn, AG Rodrigo, DC Nickle, F Li, M Mahalanabis, ... Journal of virology 79 (17), 11214-11224, 2005 | 147 | 2005 |
